Post-thrombotic syndrome is common after deep-vein thrombosis and can cause severe symptoms involving the limbs that impair patients’ activity and quality of life. Endovascular therapy can ...

X. Long Zheng, MD, PhD, gives an overview on acquired thrombotic thrombocytopenic purpura including prevalence and the typical patient presentation. X. Long Zheng, MD, PhD: What is acquired TTP? TTP ...

Endovascular therapy after deep vein thrombosis for patients with post-thrombotic syndrome and iliac vein obstruction ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

This page lists all known medications that could potentially lead to 'Thrombotic microangiopathy' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

The study, wrote the researchers, offers insight into emerging and uncommon complications following chimeric antigen receptor (CAR) T-cell therapy. Although rare, patients should be monitored for ...

Thrombotic microangiopathy due to thrombotic thrombocytopenia should be suspected in a patient with otherwise unexplained thrombocytopenia and anemia, even without fever, renal dysfunction or ...

The now well-recognized risk of thrombotic events seen in patients with COVID-19 treated at various hot spots around the United States also was seen at two Cleveland Clinic sites, one in northeast ...

This page lists all known medications that could potentially lead to 'Thrombotic thrombocytopenic purpura' as a side effect. It's important to note that mild side effects are quite common with ...